1. Home
  2. PXLW vs MURA Comparison

PXLW vs MURA Comparison

Compare PXLW & MURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pixelworks Inc.

PXLW

Pixelworks Inc.

HOLD

Current Price

$6.16

Market Cap

36.1M

Sector

Technology

ML Signal

HOLD

Logo Mural Oncology plc

MURA

Mural Oncology plc

HOLD

Current Price

$2.03

Market Cap

36.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXLW
MURA
Founded
1997
2013
Country
United States
Ireland
Employees
N/A
N/A
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
36.1M
36.0M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
PXLW
MURA
Price
$6.16
$2.03
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$14.33
$6.00
AVG Volume (30 Days)
90.3K
224.8K
Earning Date
11-11-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$33,205,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.67
$0.95
52 Week High
$15.42
$4.74

Technical Indicators

Market Signals
Indicator
PXLW
MURA
Relative Strength Index (RSI) 42.61 40.39
Support Level $5.75 $2.06
Resistance Level $6.80 $2.10
Average True Range (ATR) 0.39 0.01
MACD 0.01 -0.01
Stochastic Oscillator 34.12 25.00

Price Performance

Historical Comparison
PXLW
MURA

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

Share on Social Networks: